The MARCH family of membrane-bound E3 ubiquitin ligases comprises a group of proteins known for their role in the ubiquitination process, which marks proteins for degradation or alters their function. MARCH proteins are involved in the regulation of a variety of cellular processes, particularly those related to the immune system, such as antigen presentation and immune signaling. They function by adding ubiquitin molecules to specific target proteins, typically membrane proteins, leading to their internalization, trafficking, and sometimes degradation. This ubiquitination process is crucial for maintaining cellular homeostasis and regulating the abundance and activity of key cell surface receptors and molecules. MARCH family members, through their ligase activity, can influence signaling pathways, and their dysregulation is implicated in various diseases, including cancers and immune disorders. Additionally, the MARCH family plays a role in viral immune evasion, as some viruses have evolved MARCH-like proteins to downregulate immune molecules on the host cell surface.
Targeting the MARCH family of E3 ubiquitin ligases with small molecules for disruption or inhibition can significantly advance the understanding of their mechanistic roles in cellular processes. Inhibition of MARCH proteins allows for the study of how the controlled degradation and regulation of membrane proteins affect cell signaling and immune responses. By inhibiting the ubiquitination of specific target proteins, researchers can observe the resultant changes in cellular pathways, particularly in the context of immune cell activation and antigen presentation.
SEE ALSO...
Items 1 to 10 of 19 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Simvastatin inhibits MARCH by blocking HMG-CoA reductase, a key enzyme in cholesterol synthesis, leading to reduced cholesterol levels in cells. Lower cholesterol levels decrease MARCH activation. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
Lovastatin, like simvastatin, inhibits HMG-CoA reductase, reducing cellular cholesterol levels and indirectly inhibiting MARCH activation. | ||||||
Pravastatin, Sodium Salt | 81131-70-6 | sc-203218 sc-203218A sc-203218B | 25 mg 100 mg 1 g | $69.00 $162.00 $787.00 | 2 | |
Pravastatin inhibits cholesterol synthesis by targeting HMG-CoA reductase, which can affect MARCH activation due to reduced cholesterol levels. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $257.00 $505.00 | 9 | |
Atorvastatin inhibits HMG-CoA reductase, reducing cholesterol production and subsequently inhibiting MARCH activation. | ||||||
Rosuvastatin | 287714-41-4 | sc-481834 | 10 mg | $145.00 | 8 | |
Rosuvastatin inhibits HMG-CoA reductase, leading to decreased cholesterol synthesis and potential inhibition of MARCH. | ||||||
Simvastatin, Sodium Salt | 101314-97-0 | sc-222312 | 5 mg | $162.00 | 6 | |
Simvastatin sodium is a salt form of simvastatin and acts through the same mechanism by inhibiting HMG-CoA reductase and reducing cholesterol levels. | ||||||
Cerivastatin, Sodium Salt | 143201-11-0 | sc-207418 | 2.5 mg | $179.00 | ||
Cerivastatin inhibits HMG-CoA reductase, resulting in decreased cholesterol production, which may impact MARCH activation. | ||||||
Fluvastatin | 93957-54-1 | sc-279169 | 50 mg | $250.00 | ||
Fluvastatin sodium, a salt form of fluvastatin, inhibits HMG-CoA reductase, potentially influencing MARCH through cholesterol reduction. | ||||||
Fluvastatin, Sodium Salt | 93957-55-2 | sc-202613 sc-202613A sc-202613B | 25 mg 50 mg 100 mg | $93.00 $138.00 $246.00 | 1 | |
Lovastatin sodium, a salt form of lovastatin, inhibits HMG-CoA reductase and indirectly affects MARCH activity through cholesterol reductio | ||||||
Pomalidomide | 19171-19-8 | sc-364593 sc-364593A sc-364593B sc-364593C sc-364593D sc-364593E | 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $100.00 $143.00 $312.00 $468.00 $1248.00 $1997.00 | 1 | |
Similar to thalidomide and lenalidomide, affects ubiquitin ligase activity. | ||||||